Literature DB >> 30203467

Power and sample size for dose-finding studies with survival endpoints under model uncertainty.

Qiqi Deng1, Xiaofei Bai1, Dacheng Liu1, Dooti Roy1, Zhiliang Ying2, Dan-Yu Lin3.   

Abstract

Multiple comparison procedures combined with modeling techniques (MCP-Mod) (Bretz et al., 2005) is an efficient and robust statistical methodology for the model-based design and analysis of dose-finding studies with an unknown dose-response model. With this approach, multiple comparison methods are used to identify statistically significant contrasts corresponding to a set of candidate dose-response models, and the best model is then used to estimate the target dose. Power and sample size calculations for this methodology require knowledge of the covariance matrix for the estimators of the (placebo-adjusted) mean responses among the dose groups. In this article, we consider survival endpoints and derive an analytic form of the covariance matrix for the estimators of the log hazard ratios as a function of the total number of events in the study. We then use this closed-form expression of the covariance matrix to derive the power and sample size formulas. We discuss practical considerations in the application of these formulas. In addition, we provide an illustration with a motivating example on chronic obstructive pulmonary disease. Finally, we demonstrate through simulation studies that the proposed formulas are accurate enough for practical use.
© 2018, The International Biometric Society.

Entities:  

Keywords:  Clinical trial; Dose-response; MCP-Mod; Power and sample size calculation; Proportional hazards; Survival data

Mesh:

Year:  2018        PMID: 30203467      PMCID: PMC6411454          DOI: 10.1111/biom.12968

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  1 in total

1.  Plasma testosterone and arrhythmic events in male patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Jie Ren; Liang Chen; Ningning Zhang; Xiao Chen; Qian Zhao; Kai Chen; Xiangjie Li; Frank Ruschitzka; Firat Duru; Jiangping Song
Journal:  ESC Heart Fail       Date:  2020-05-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.